Clinical Trial Update: A Study Comparing the Efficacy of an Alpha Blocker Versus an Alpha Blocker Plus Solifenacin in Men With Overactive Bladder [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing an alpha blocker alone versus alpha blocker plus solifenacin in men with overactive bladder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Alpha blocker
• Solifenacin (solifenacin)

Snippet

Sponsor: KYU-SUNG LEE | Conditions: Urinary Bladder, Overactive | Phase 4 | Status: COMPLETED